New Key Statistics Module, Z-Score and F-Score
OTCPK:CRTHF Key Ratios
Market Cap $ M | 455.51 |
Enterprise Value $ M | 211.86 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.59 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.19 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.51 |
EV-to-EBITDA | -1.54 |
PEG | -- |
Shares Outstanding M | 575.64 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 9.54 |
Current Ratio | 9.55 |
ROA % (ttm) | -29.05 |
ROE % (ttm) | -34.34 |
ROIC % (ttm) | -128.05 |
Dividend Yield % | -- |
Altman Z-Score | -- |
CRTHF Number of Guru Trades
CRTHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CRTHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CRTHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CARsgen Therapeutics Holdings Ltd Insider Transactions
No Available Data
News about OTCPK:CRTHF
Total 0- 1